1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Fertility, pregnancy and childbirth
  5. Intrapartum care

Lumella point-of-care test for assessing pre-eclampsia risk

Medtech innovation briefing [MIB287] Published: 01 March 2022

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Patient organisation comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

NICE has developed a medtech innovation briefing (MIB) on Lumella point-of-care test for assessing pre-eclampsia risk.

What are MIBs?


  • Next